Cytovance Biologics and PolyPeptide Announce Collaboration for Microbial and Mammalian-Expressed Peptide Drugs
This collaboration offers an integrated solution for customers seeking to outsource the development and manufacturing of microbial and mammalian-expressed peptide drugs, with scalable options that address the full range of product requirements.
In response to the growing demand for peptide drugs, Cytovance Biologics and PolyPeptide have announced a partnership that combines Cytovance’s expertise in microbial and mammalian expression, process development and cGMP manufacturing with PolyPeptide’s capabilities in complex peptide development and manufacturing.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113598664/en/
Axel Schleyer, CCO of Cytovance Biologics: “Cytovance has been supporting the development and scale-up of microbial and mammalian-expressed biologics for two decades. Combining our strengths with PolyPeptide’s is exactly what our customers and the industry need to support the rapidly advancing market demand.”
Trishul Shah, PolyPeptide Director of Business Development: “With a track record of over 1,000 therapeutic peptides manufactured, PolyPeptide offers deep peptide development and synthesis capabilities. The collaboration gives customers access to complementary technology portfolios to drive their innovative drug development projects.”
The two companies have partnered before on specific customer projects. The new collaboration broadens the partnership to the benefit of drug developers looking for additional capacity, fast ramp-up, and increased efficiency, helping to propel new peptide products to the clinic and the market.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250113598664/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AEM Launches WMO-Compliant Automated Weather Station to Elevate Global Weather Monitoring13.1.2025 16:00:00 CET | Press release
AEM, the essential source for environmental insights, today announced its WMO-compliant AEM Apex Automated Weather Station (AWS). This state-of-the-art solution sets a new benchmark for precision, reliability, and durability, meeting the strict standards of the World Meteorological Organization (WMO). Designed to address the toughest challenges in weather monitoring, the WMO-compliant AWS offers unparalleled accuracy and performance for a variety of critical applications, from localized climate research to large-scale weather networks. Key Benefits of the WMO-Compliant AWSPrecision Data for Better Decisions: Provides WMO-compliant measurements with strict tolerances to support critical applications. Seamless Global Collaboration: Enables efficient data sharing with regional and global partners, fostering enhanced coordination for monitoring and forecasting. Reliability in Extreme Conditions: Built to deliver continuous, accurate data with minimal maintenance, even in the most demanding
Greenland Resources Signs Advisory Agreement With Rasmussen Global on Defense13.1.2025 15:30:00 CET | Press release
Greenland Resources Inc. (Cboe CA: MOLY | FSE: M0LY) “Greenland Resources” or the “Company”) is pleased to announce that it has signed an advisory agreement with Rasmussen Global to complement the Malmbjerg Project existing funding strategy through potential strategic supranational partners, including the North Atlantic Treaty Organization (NATO) Innovation Fund and the European Defense Fund. Rasmussen Global was founded and is chaired by Anders Fogh Rasmussen, the former Prime Minister of Denmark and former Secretary General of NATO. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113410398/en/ The Project is strategically located in east central Greenland and based on its current NI 43-101 Feasibility Study, can supply some 25% of the European Union (EU) total molybdenum consumption for decades to come including nearly all the EU defense needs. Currently, the EU is the 2nd largest molybdenum user in the world and has no
Starr Names Peter Hirs to Succeed Howard Smith as CFO13.1.2025 15:30:00 CET | Press release
Starr announced that Peter Hirs has been named the company’s chief financial officer, effective January 13, succeeding Howard I. Smith, who is retiring after more than 40 years at Starr and related entities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113071409/en/ Peter Hirs, chief financial officer, Starr (Photo: Business Wire) Hirs brings significant finance and insurance experience to Starr, having spent the past 20 years at a global insurance carrier, where he managed regional finance teams across the world and led mergers and acquisitions activities. In his new role, Hirs will oversee the organization’s global finance operations. He is based at Starr’s head office in New York. Smith had led Starr’s financial operations since 2005, when Maurice R. “Hank” Greenberg, Starr’s chairman emeritus, re-established Starr as a free-standing investment and insurance organization, and he worked closely with Hank prior to that
Moody’s to Acquire CAPE Analytics, Adding AI-Powered Geospatial Property Risk Intelligence to Its Industry-Leading Insurance Risk Models13.1.2025 14:00:00 CET | Press release
Moody’s Corporation (NYSE:MCO) announced today that it has entered into an agreement to acquire CAPE Analytics, a leading provider of geospatial AI intelligence for residential and commercial properties. The acquisition will bring together Moody’s industry-leading Intelligent Risk Platform and catastrophe risk modeling for the insurance sector with CAPE's cutting-edge geospatial AI analytics, creating a sophisticated property database capable of delivering instant, address-specific risk insights. “I continually hear from our customers that they are seeking more precise and actionable information as they evaluate an evolving set of risks,” said Rob Fauber, President and Chief Executive Officer of Moody’s. “By combining our CAT risk models with CAPE’s AI-powered property risk intelligence, we will provide our customers with the most advanced property risk analytics available in the industry, enhancing insights and decision-making across the insurance lifecycle.” With the acquisition of C
Landmark Clinical Study Validates Patch-Based Onera Home-Polysomnography System in One of the Largest Sleep Diagnostic Trials of the Decade13.1.2025 14:00:00 CET | Press release
Study demonstrates comparable performance between wireless, patch-based Onera Sleep Test System and in-lab polysomnography for sleep staging and respiratory event detection. Onera Health, a leader in transforming sleep medicine and remote monitoring, today announced the publication of a multicenter validation study of its Onera Sleep Test System (STS) in the Journal of Clinical Sleep Medicine, the official journal of the American Academy of Sleep Medicine. The study demonstrated that the patch-based Onera STS home-polysomnography (hPSG) performs comparably to gold-standard in-lab polysomnography (PSG) for both sleep staging and respiratory event detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113111691/en/ A woman is conducting a sleep test (polysomnography) using the patch-based Onera STS hPSG system. (Photo: Business Wire) The international multicenter study was managed by an independent Clinical Research Orga
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom